Close
Xylem
Novotech

The CPhI Annual Report: take part in pharma’s largest reputation survey

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Knowledge Graphs Improving Pharmaceutical Intelligence

Connecting disparate datasets into a unified semantic network to uncover hidden relationships between diseases, drugs, and genetic markers, accelerating discovery and operational decision-making.
- Advertisement -

The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients.

CPhI Worldwide is using its unrivalled access to pharmaceutical professionals and supplier companies to produce its third annual global survey of the major trends, changes and developments in the industry. This invaluable research will rank the relative reputations of the major pharma economies โ€“ from China and India to the USA, Japan, and Europe โ€“ creating pharma league tables across areas such as โ€˜API productionโ€™, โ€˜finished dosage formulationsโ€™, โ€˜biologicsโ€™, โ€˜growth potentialโ€™, โ€˜innovationโ€™ โ€˜regulatory acumenโ€™, and โ€˜drug delivery technologyโ€™ amongst others.

Covering small molecule, biologics and drug delivery and packaging, the insights provided are integral to building a global picture of the state and strength of the international pharma industry.ย Investment decisions and supply-side arrangements can often hinge on this unspoken influence, particularly when working with new partners.

The Report provides the industry with an in-depth, holistic analysis that will help you make better-informedย decisions and meet the evolving pharma business landscape.

The results of this survey are completelyย anonymous and will be available on the CPhI Annual Report webpage.

Please take the survey here:ย https://www.surveymonkey.co.uk/r/CPhIAnnual19

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Knowledge Graphs Improving Pharmaceutical Intelligence

Connecting disparate datasets into a unified semantic network to uncover hidden relationships between diseases, drugs, and genetic markers, accelerating discovery and operational decision-making.

Digital Product Passports Enhancing Pharma Traceability

Revolutionizing pharmaceutical supply chains through decentralized digital identities that track drug lifecycles from manufacturing to patient delivery, ensuring authenticity and regulatory compliance.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป